Neurocrine Biosciences, Inc. (0K6R.L)

USD 138.27

(1.59%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 1.88 Billion 1.48 Billion 1.13 Billion 1.04 Billion 788.1 Million 451.24 Million
Cost of Revenue 39.7 Million 23.2 Million 14.3 Million 10.1 Million 7.4 Million 4.88 Million
Gross Profit 1.84 Billion 1.46 Billion 1.11 Billion 1.03 Billion 780.7 Million 446.35 Million
Operating Expenses 1.59 Billion 1.21 Billion 911.4 Million 708.3 Million 554.1 Million 409.45 Million
Selling, General and Administrative Expenses 887.6 Million 752.7 Million 583.3 Million 433.3 Million 354.1 Million 248.93 Million
Research and Development Expenses 565 Million 463.8 Million 328.1 Million 275 Million 200 Million 160.52 Million
Other Expenses 143.9 Million - 105.3 Million 164.5 Million 154.27 Million -
Cost and Expenses 1.63 Billion 1.23 Billion 925.7 Million 718.4 Million 561.5 Million 414.34 Million
Operating Income 250.9 Million 249 Million 196.9 Million 318.9 Million 219.14 Million 36.89 Million
Interest Expense 4.6 Million 7.1 Million 25.8 Million 32.8 Million 32 Million 30.53 Million
Income Tax Expense 82.4 Million 59.4 Million 11.8 Million -300.6 Million 9.5 Million 730 Thousand
Earnings before Tax 332.1 Million 213.9 Million 101.4 Million 106.7 Million 46.5 Million 21.84 Million
Net Income 249.7 Million 154.5 Million 89.6 Million 407.3 Million 37 Million 21.11 Million
Earnings Per Share Basic 2.56 1.61 0.95 4.37 0.40 0.22
Earnings Per Share Diluted 2.47 1.56 0.92 4.16 0.39 0.22
Weighted Average Shares Outstanding 97.7 Million 95.8 Million 94.6 Million 93.1 Million 91.62 Million 95.4 Million
Weighted Average Shares Outstanding (Diluted) 101 Million 98.9 Million 97.9 Million 97.8 Million 95.73 Million 95.4 Million
Gross Margin 0.98 0.98 0.99 0.99 0.99 0.99
EBIT Margin 0.22 0.17 0.18 0.31 0.29 0.08
Profit Margin 0.13 0.10 0.08 0.39 0.05 0.05
EBITDA 416.1 Million 264.6 Million 218.7 Million 336.1 Million 226.6 Million 56.39 Million
Earnings Before Tax Margin 0.13 0.17 0.17 0.30 0.28 0.08

Income Statement Charts